PAX Financial Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-9,650
Closed -$570K 233
2024
Q2
$570K Buy
9,650
+2,250
+30% +$141K 0.11% 157
2024
Q1
$590K Sell
7,400
-426
-5% -$32.5K 0.12% 164
2023
Q4
$588K Sell
7,826
-864
-10% -$61.5K 0.12% 163
2023
Q3
$607K Buy
8,690
+248
+3% +$17.6K 0.14% 138
2023
Q2
$584K Buy
8,442
+149
+2% +$10.6K 0.13% 141
2023
Q1
$616K Buy
8,293
+437
+6% +$36.6K 0.15% 115
2022
Q4
$732K Sell
7,856
-838
-10% -$80.9K 0.19% 89
2022
Q3
$829K Sell
8,694
-286
-3% -$28.3K 0.21% 71
2022
Q2
$832K Buy
8,980
+466
+5% +$45.5K 0.21% 70
2022
Q1
$862K Buy
8,514
+249
+3% +$26.2K 0.2% 85
2021
Q4
$853K Sell
8,265
-90
-1% -$8.32K 0.19% 87
2021
Q3
$709K Buy
8,355
+43
+0.5% +$3.6K 0.17% 102
2021
Q2
$694K Buy
8,312
+327
+4% +$26.8K 0.18% 95
2021
Q1
$601K Buy
7,985
+495
+7% +$36.1K 0.17% 96
2020
Q4
$512K Buy
7,490
+294
+4% +$19.1K 0.16% 90
2020
Q3
$420K Buy
7,196
+480
+7% +$29.9K 0.15% 100
2020
Q2
$436K Buy
6,716
+157
+2% +$9.89K 0.17% 82
2020
Q1
$409K Buy
6,559
+2,079
+46% +$139K 0.17% 67
2019
Q4
$323K Buy
+4,480
New +$315K 0.14% 78

Other funds holding CVS

PAX Financial Group's CVS Position: Q3 2024 in Review

PAX Financial Group sold out of CVS Health (CVS) in Q3 2024, closing a stake of 9,650 shares — an estimated $570K sold.

PAX Financial Group first reported a position in CVS in Q4 2019 and held it in 19 quarters. The position peaked at $862K in Q1 2022. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

  • PAX Financial Group reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
  • PAX Financial Group sold 9,650 CVS Health shares in Q3 2024, an estimated $570K.
  • PAX Financial Group first reported a position in CVS Health in Q4 2019 and held it in 19 quarters.
  • PAX Financial Group's CVS Health position peaked at $862K in Q1 2022.
  • 1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on PAX Financial Group's 13F filing for Q3 2024, filed 13 Nov 2024.